The US Food and Drug Administration (FDA) on Oct 5 announced that it approved expanded use of Gardasil 9 human papillomavirus (HPV) vaccine for women and men 27 through 45 years old. The vaccine prevents certain cancers and diseases caused by the nine HPV types contained in the vaccine.
The oropharyngeal cancer rate increased 2.8% per year in men and 0.6% in women.
Preteen girls, teens, and young women who receive recommended vaccinations, including for human papillomavirus (HPV), have no increased risk of primary ovarian insufficiency (POI), also called premature menopause, according to a study published yesterday in Pediatrics.
The value of human papillomavirus (HPV) testing as an additional tool to screen for cervical cancer—joining the traditional Pap smear—has been affirmed by a new meta-analysis and an expert panel’s recommendation based on that analysis, as explained in a set of articles today in the Journal of the American Medical Association (JAMA).
Former smokers had triple the risk, while those with more than 6 sex partners had a sixfold risk.
The results confirm, however, that the vaccine is most effective when given at younger ages.
Public Health England (PHE) yesterday released its provisional seasonal flu vaccine effectiveness (VE) estimates for the 2017-18 flu season, which revealed low overall effectiveness and no protection against H3N2, but variable findings in different age-groups.
With intensive efforts under way to identify any potential remaining Ebola cases in the Democratic Republic of the Congo (DRC), the health ministry yesterday reported 10 more suspected cases, according to the latest update.
The Centers for Disease Control and Prevention (CDC) today confirmed 28 new cases of Escherichia coli infections and four newly affected states in an outbreak tied to eating romaine lettuce from the Yuma, Ariz., growing region that has caused higher rates of severe disease than is typically seen with E coli.
In response to cholera outbreaks in several African countries over the past several months, the World Health Organization (WHO) today announced the largest cholera vaccination drive in history, with a goal of reaching 2 million people.
